Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06322888
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-03-01
Brief Title:
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts REP-D
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Study Overview
Official Title:
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts REP-D
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to learn more about how exercise might lower the risk of developing breast cancer in women with dense breast tissue by studying changes that occur in breast tissue and blood as a result of participating in an exercise program
The names of the study groups in this study are
Exercise Training Group
Waitlist Control Group
The names of the study groups in this study are
Exercise Training Group
Waitlist Control Group
Detailed Description:
The goal of this study is to learn more about how exercise might lower the risk of developing breast cancer by studying changes that occur in breast tissue and blood as a result of participating in an exercise program Participants will be placed into one of two study groups Exercise Training Group vs Waitlist Control Group Randomization means that a participant is put into a group by chance
The research study procedures include screening for eligibility and baseline and end of study assessments which include breast biopsies assessment of physical activity habits aerobic and strength testing blood draws and questionnaires
Participants randomized to the exercise group will be expected to participate in exercise sessions throughout the study They will also be asked to complete logs of their activity
Participants will be in this research study for up to 16 weeks
It is expected that 46 women will take part in this study
The Breast Cancer Research Foundation is supporting this research study by providing funding
The research study procedures include screening for eligibility and baseline and end of study assessments which include breast biopsies assessment of physical activity habits aerobic and strength testing blood draws and questionnaires
Participants randomized to the exercise group will be expected to participate in exercise sessions throughout the study They will also be asked to complete logs of their activity
Participants will be in this research study for up to 16 weeks
It is expected that 46 women will take part in this study
The Breast Cancer Research Foundation is supporting this research study by providing funding
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None